Funding

>

Latest News

Michelle Hoffmann, PhD
How Chicago is Strategizing Around NIH Funding Cuts: Q&A with Michelle Hoffmann

April 28th 2025

The emerging biotech scene in Chicago has the potential to develop new treatments and technologies, but funding cuts from the federal government could have significant impact on this.

Merida Biosciences Launches with $121 Million in Series A Financing to Develop Precision Therapeutics for Autoimmune, Allergic Diseases
Merida Biosciences Launches with $121 Million in Series A Financing to Develop Precision Therapeutics for Autoimmune, Allergic Diseases

April 10th 2025

Talphera Cuts NEPHRO CRRT Study Size, Secures $14.8 Million Private Placement
Talphera Cuts NEPHRO CRRT Study Size, Secures $14.8 Million Private Placement

April 1st 2025

Merck Reaches Licensing Agreement with Jiangsu Hengrui for Novel Heart Disease Drug
Merck Reaches Licensing Agreement with Jiangsu Hengrui for Novel Heart Disease Drug

March 25th 2025

Novo Nordisk, The United Laboratories Ink Exclusive License Agreement for Triple Receptor Agonist
Novo Nordisk, The United Laboratories Ink Exclusive License Agreement for Triple Receptor Agonist

March 25th 2025

More News